|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Weberpals JI, Koti M and Squire JA:
Targeting genetic and epigenetic alterations in the treatment of
serous ovarian cancer. Cancer Genet. 204:525–535. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jayson GC, Kohn EC, Kitchener HC and
Ledermann JA: Ovarian cancer. Lancet. 384:1376–1388. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ahmed AA and Abdou AM: Diagnostic accuracy
of CA125 and HE4 in ovarian carcinoma patients and the effect of
confounders on their serum levels. Curr Probl Cancer.
S0147-0272(18)30164-8. 2019. View Article : Google Scholar
|
|
5
|
Dochez V, Caillon H, Vaucel E, Dimet J,
Winer N and Ducarme G: Biomarkers and algorithms for diagnosis of
ovarian cancer: CA125, HE4, RMI and ROMA, a review. J Ovarian Res.
12:282019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Pecci A, Ma X, Savoia A and Adelstein RS:
MYH9: Structure, functions and role of non-muscle myosin IIA in
human disease. Gene. 664:152–167. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liang S, He L, Zhao X, Miao Y, Gu Y, Guo
C, Xue Z, Dou W, Hu F, Wu K, et al: MicroRNA let-7f inhibits tumor
invasion and metastasis by targeting MYH9 in human gastric cancer.
PLoS One. 6:e184092011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Park SY, Kim H, Yoon S, Bae JA, Choi SY,
Jung YD and Kim KK: KITENIN-targeting microRNA-124 suppresses
colorectal cancer cell motility and tumorigenesis. Mol Ther.
22:1653–1664. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Xia ZK, Yuan YC, Yin N, Yin BL, Tan ZP and
Hu YR: Nonmuscle myosin IIA is associated with poor prognosis of
esophageal squamous cancer. Dis Esophagus. 25:427–436. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hosono Y, Usukura J, Yamaguchi T,
Yanagisawa K, Suzuki M and Takahashi T: MYBPH inhibits NM IIA
assembly via direct interaction with NMHC IIA and reduces cell
motility. Biochem Biophys Res Commun. 428:173–178. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Katono K, Sato Y, Jiang SX, Kobayashi M,
Nagashio R, Ryuge S, Fukuda E, Goshima N, Satoh Y, Saegusa M and
Masuda N: Prognostic significance of MYH9 expression in resected
non-small cell lung cancer. PLoS One. 10:e01214602015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Derycke L, Stove C, Vercoutter-Edouart AS,
De Wever O, Dollé L, Colpaert N, Depypere H, Michalski JC and
Bracke M: The role of non-muscle myosin IIA in aggregation and
invasion of human MCF-7 breast cancer cells. Int J Dev Biol.
55:835–840. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liao Q, Li R, Zhou R, Pan Z, Xu L, Ding Y
and Zhao L: LIM kinase 1 interacts with myosin-9 and
alpha-actinin-4 and promotescolorectal cancer progression. Br J
Cancer. 117:563–571. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ye G, Huang K, Yu J, Zhao L, Zhu X, Yang
Q, Li W, Jiang Y, Zhuang B, Liu H, et al: MicroRNA-647 targets
SRF-MYH9 axis to suppress invasion and metastasis of gastric
cancer. Theranostics. 7:3338–3353. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Schramek D, Sendoel A, Segal JP, Beronja
S, Heller E, Oristian D, Reva B and Fuchs E: Direct in vivo RNAi
screen unveils myosin IIa as a tumor suppressor of squamous cell
carcinomas. Science. 343:309–313. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Coaxum SD, Tiedeken J, Garrett-Mayer E,
Myers J, Rosenzweig SA and Neskey DM: The tumor suppressor
capability of p53 is dependent on non-muscle myosin IIA function in
head and neck cancer. Oncotarget. 8:22991–23007. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wei XH, Lin SS, Liu Y, Zhao RP, Khan GJ,
Du HZ, Mao TT, Yu BY, Li RM, Yuan ST and Sun L: DT-13 attenuates
human lung cancer metastasis via regulating NMIIA activity under
hypoxia condition. Oncol Rep. 36:991–999. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Conti MA, Saleh AD, Brinster LR, Cheng H,
Chen Z, Cornelius S, Liu C, Ma X, Van Waes C and Adelstein RS:
Conditional deletion of nonmuscle myosin II-A in mouse tongue
epithelium results in squamous cell carcinoma. Sci Rep.
5:140682015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kas SM, de Ruiter JR, Schipper K,
Annunziato S, Schut E, Klarenbeek S, Drenth AP, van der Burg E,
Klijn C, Ten Hoeve JJ, et al: Insertional mutagenesis identifies
drivers of a novel oncogenic pathway in invasive lobular breast
carcinoma. Nat Genet. 49:1219–1230. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu L, Zeng Z, Yi J, Zuo L, Lv J, Yuan J,
Lin Z, Luo R and Feng X: Expression and clinical significance of
transcription factor 4 (TCF4) in epithelial ovarian cancer. Cancer
Biomark. 24:213–221. 2019. View Article : Google Scholar : PubMed/NCBI
|
